Regulation (EU) 2022/20
Commission Implementing Regulation (EU) 2022/20 of 7 January 2022 laying down rules for the application of Regulation (EU) No 536/2014 of the European Parliament and of the Council as regards setting up the rules and procedures for the cooperation of the Member States in safety assessment of clinical trials (Text with EEA relevance)
In forceTyperegulationDate7 Jan 2022Since13 Feb 2023Articles15Versions held48Cited by1 documents
- 3Selection of the safety assessing Member State
- 4Changing the Safety Assessing Member State
- 5Role and tasks of the safety assessing Member State
- 6Screening and assessment of suspected unexpected serious adverse reactions
- 7The assessment of the annual safety reports
- 8Recommendations of corrective measures and other actions for safety oversight related to the active substanc
- 9The role of the Member States concerned and the reporting Member States in the coordinated safety assessment
- 10Lead safety assessing Member State
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).